Stereotaxis (STXS) is transitioning to higher-margin recurring revenue streams, with new products, like MAGiC and Genesis X, accelerating growth and revenue visibility. Q2 2025 showed strong recurring ...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or ...